CAN THE '4 P'S OF PN' IMPROVE NEONATAL NUTRIENT INTAKE?

Zoe Lansdowne1, Elizabeth Griffiths1

  • 1Sheffield Teaching Hospitals NHS Foundation Trust.

Insights

Implementing the "4 P's of Parenteral Nutrition" (PN) significantly improved protein intake and growth velocity in extremely low birth weight (ELBW) infants. This initiative reduced time to PN initiation and increased protein delivery, leading to better outcomes.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Clinical Auditing

Background:

  • Extremely low birth weight (ELBW) infants often experience poor growth.
  • Previous audits identified delays in parenteral nutrition (PN) initiation and suboptimal protein intake.
  • Unit guidelines were established to improve PN timing and nutritional support.

Purpose of the Study:

  • To evaluate the impact of publicizing the "4 P's of PN" (prompt, protein, protected, peripheral) on protein intake.
  • To assess the effect of improved protein intake on growth velocity in ELBW infants.
  • To analyze changes in PN delivery and nutritional outcomes over two audit cycles.

Main Methods:

  • Retrospective analysis of ELBW infants' data (<28 weeks gestation or <1kg) across two 3-month audit periods.
  • Data collection included PN prescriptions, fluid orders, and observation charts from medical records.
  • Interventions included publicizing PN guidelines and reformulating concentrated PN stock recipes.

Main Results:

  • Mean time to PN initiation for inborn infants decreased significantly over the audits (from 10h 59m to 4h 16m).
  • Mean protein intake in the first 24 hours increased, with a notable rise for inborn infants (0.66g/kg/day to 1.38g/kg/day).
  • Average weight gain improved from 2.97g/kg/day to over 7g/kg/day, with all infants regaining birth weight by day 14 in later audits.

Conclusions:

  • Publicizing the "4 P's of PN" effectively improved timely initiation and increased protein intake on day 1.
  • Concentrated PN recipes and protected PN volumes contributed to enhanced protein delivery.
  • The interventions led to improved growth velocity and successful birth weight regain by day 14.
Abstract

Keywords:
AbstractOral

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312